
All in on amyloid, Acumen Pharma’s IPO raises $160M for Alzheimer’s drug R&D
Acumen Pharmaceuticals’ IPO raised $160 million to fund clinical development of its Alzheimer’s disease drug candidate. Though that drug goes after the same target as […]
Acumen Pharmaceuticals’ IPO raised $160 million to fund clinical development of its Alzheimer’s disease drug candidate. Though that drug goes after the same target as […]
Copyright © 2022 | WordPress Theme by MH Themes